close
MENU
2 mins to read

Truscreen’s early investors sell down

Truscreen announced a capital raising on Wednesday to fund growth plans in Asia.

Tim Hunter
Wed, 20 May 2015

Several early shareholders in healthcare company Truscreen [NZX: TRU] sold down their holdings within days of the company listing last November, trading records show.

Truscreen, a marketer of cancer screening technology acquired from defunct Australian company Polartechnics, announced a capital

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Tim Hunter
Wed, 20 May 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Truscreen’s early investors sell down
47868
true